Delivery Order SPE2DB20D1109-SPE2DB20FN01G
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order under the company's Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical, valued at up to $999,999,999.00 through December 2025. The contract covers the delivery of a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits,...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at up to $999,999,999.00, is for the provision of a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare programs, and other federal medical institutions worldwide. The contract...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is an Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 with the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of a comprehensive range of pharmaceutical products and medical supplies to support military treatment programs and facilities worldwide. The IDC, which runs through December 31, 2025, serves as the primary vehicle for Amerisourcebergen...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The contract, which has no set-aside designation, covers the delivery of a wide range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support...
- This federal contract award is for a five-year Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 between the Defense Logistics Agency (DLA) Troop Support Medical and Cencora, Inc., doing business as Amerisourcebergen. The contract covers the delivery of a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name drugs, generic pharmaceuticals, and critical care materials such as syringes, vials, and test kits. This IDC...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The single-award Indefinite Delivery Contract (IDC), valued at up to $999,999,999.00, runs through December 31, 2025 and serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to support military and veteran healthcare...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical valued at up to $999,999,999.00. The contract covers the delivery of a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military treatment...
- This federal contract award is for delivery orders under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., with the Defense Logistics Agency (DLA) Troop Support Medical. The IDC, valued at up to $999,999,999.00, runs through November 2026 and covers the delivery of a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities, veterans' healthcare programs, and other federal medical...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00. The contract, which runs through November 2026, covers the delivery of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This includes specialty medications, brand-name and generic...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., to deliver a wide range of pharmaceutical products, medical supplies, and equipment. The contract, valued at $1,210.55, is a delivery order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a potential value of up to $999,999,999.00 and runs through November 2026. This IDC serves as the primary vehicle for...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB20FN01GDelivery Order
This federal contract award is for a delivery order under an Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $4,849.37, covers the delivery of a wide range of pharmaceutical products and medical supplies to support military treatment facilities and veterans' healthcare programs. The IDC held by Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a single-award contract valued up to $999,999,999.00 and runs through November 2026. This contract serves as the primary vehicle for the company to provide essential medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and other critical care materials across multiple therapeutic areas. The contract does not have a set-aside designation, indicating open competition. In addition to the DLA contract, Amerisourcebergen also holds a separate IDC with the Department of Justice Federal Bureau of Investigation, valued up to $750,000 through May 2024, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.8k | 8/14/20 |